Open-angle Glaucoma
📧 Sign up to get email alerts when something new happens for Open-angle Glaucoma.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2023-08-01FDA Approved: BRIMONIDINE TARTRATE — Original Application (Alembic Pharmaceuticals Limited)
FDA approved brimonidine tartrate for an original application (ANDA) from Alembic Pharmaceuticals Limited.
-
FDA approval · 2023-06-28FDA Approved: BRINZOLAMIDE — Supplemental Application (Sandoz Inc)
The FDA approved a supplemental application for brinzolamide from Sandoz Inc, signaling a regulatory update to the product.
-
FDA approval · 2023-05-08FDA Approved: TIMOLOL MALEATE — Original Application (Armas Pharmaceuticals, Inc.)
FDA approved TIMOLOL MALEATE as an Original Application (ANDA) for Armas Pharmaceuticals, a generic ophthalmic solution indicated to reduce …
-
FDA approval · 2023-05-05FDA Approved: SIMBRINZA — Supplemental Application (Alcon Laboratories, Inc.)
FDA approves a supplemental application for Simbrinza (brinzolamide/brimonidine tartrate) from Alcon Laboratories, Inc.
-
FDA approval · 2023-05-01FDA Approved: DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE — Original Application (Ingenus Pharmaceuticals, LLC)
FDA approved Ingenus Pharmaceuticals' original application for a dorzolamide hydrochloride and timolol maleate combination eye drop to reduc…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2023-04-04FDA Approved: ACETAZOLAMIDE — Original Application (Zydus Lifesciences Limited)
FDA approved a generic acetazolamide product from Zydus Lifesciences Limited under an Original Application (ANDA211069).
-
FDA approval · 2023-03-29FDA Approved: BRIMONIDINE TARTRATE OPHTHALMIC SOLUTION, 0.15% — Original Application (Alembic Pharmaceuticals Limited)
FDA approves Brimonidine tartrate ophthalmic solution 0.15% from Alembic Pharmaceuticals as an Original Application (ANDA) for lowering intr…
-
FDA approval · 2023-03-23FDA Approved: TIMOLOL MALEATE — Original Application (Aurobindo Pharma Limited)
FDA approves original ANDA for timolol maleate ophthalmic solution from Aurobindo Pharma Limited, enabling a generic version for lowering in…
-
FDA approval · 2022-12-13FDA Approved: IYUZEH — Original Application (Thea Pharma Inc.)
FDA approved IYUZEH, latanoprost ophthalmic solution 0.005%, under an original NDA from Thea Pharma Inc. for reducing intraocular pressure i…
-
FDA approval · 2022-12-12FDA Approved: BRIMONIDINE TARTRATE AND TIMOLOL MALEATE — Original Application (Upsher-Smith Laboratories, LLC)
FDA approves Upsher-Smith's original application for a generic fixed-dose combination of brimonidine tartrate and timolol maleate ophthalmic…
-
FDA approval · 2022-12-05FDA Approved: LATANOPROST — Supplemental Application (Somerset Therapeutics, LLC)
The FDA approved a supplemental application for latanoprost from Somerset Therapeutics, LLC. Latanoprost is used to lower intraocular pressu…
-
FDA approval · 2022-12-01FDA Approved: BIMATOPROST — Supplemental Application (Apotex Corp.)
FDA approved a supplemental application for Bimatoprost from Apotex Corp. under an Abbreviated New Drug Application (ANDA). The approval con…
-
FDA approval · 2022-11-22FDA Approved: TIMOLOL MALEATE — Supplemental Application (Sandoz Inc)
FDA approved a supplemental application for timolol maleate from Sandoz Inc, supporting an additional generic ophthalmic product. Timolol ma…
-
FDA approval · 2022-11-08FDA Approved: BIMATOPROST — Supplemental Application (Sandoz Inc)
The FDA approved a supplemental application for bimatoprost from Sandoz Inc.
-
FDA approval · 2022-10-04FDA Approved: BRIMONIDINE TARTRATE AND TIMOLOL MALEATE — Original Application (Florida Pharmaceutical Products, LLC)
FDA approved a generic combination product of brimonidine tartrate and timolol maleate for lowering intraocular pressure in glaucoma or ocul…
-
FDA approval · 2022-09-22FDA Approved: OMLONTI — Original Application (Ocuvex Therapeutics, Inc.)
The FDA approved OMLONTI (omidenepag isopropyl) from Ocuvex Therapeutics as an Original Application (NDA 215092) for reducing intraocular pr…
-
FDA approval · 2022-09-22FDA Approved: OMLONTI — Supplemental Application (Ocuvex Therapeutics, Inc.)
The FDA approved a supplemental application for OMLONTI (omidenepag isopropyl) from Ocuvex Therapeutics, expanding the approved use of the o…
-
FDA approval · 2022-09-19FDA Approved: DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE — Original Application (Gland Pharma Limited)
The FDA approved Gland Pharma Limited's generic dorzolamide hydrochloride and timolol maleate ophthalmic solution (ANDA 215520) for lowering…
-
FDA approval · 2022-09-13FDA Approved: TIMOLOL MALEATE — Original Application (Ingenus Pharmaceuticals, LLC)
FDA approved Ingenus Pharmaceuticals' original ANDA for Timolol Maleate ophthalmic solution, sanctioning a generic treatment option for open…
-
FDA approval · 2022-09-07FDA Approved: TIMOLOL MALEATE — Original Application (Micro Labs Limited)
FDA approved timolol maleate from Micro Labs Limited under an original application (ANDA) for lowering intraocular pressure in open-angle gl…
-
FDA approval · 2022-06-24FDA Approved: TIMOLOL MALEATE OPHTHALMIC GEL FORMING SOLUTION — Original Application (FOSUN PHARMA USA INC)
FDA approved TIMOLOL MALEATE OPHTHALMIC GEL FORMING SOLUTION from Fosun Pharma USA Inc as an original ANDA product for lowering intraocular …
-
FDA approval · 2022-04-20FDA Approved: BRIMONIDINE TARTRATE/TIMOLOL MALEATE OPHTHALMIC SOLUTION — Original Application (Apotex Corp.)
FDA approved Apotex's brimonidine tartrate/timolol maleate ophthalmic solution as an Original Application generic to lower intraocular press…
-
FDA approval · 2022-01-28FDA Approved: TAFLUPROST — Original Application (Sandoz Inc)
FDA approves Sandoz's Tafluprost as an original application (ANDA) for generic tafluprost indicated to reduce intraocular pressure in open-a…
-
FDA approval · 2021-12-13FDA Approved: TIMOPTIC IN OCUDOSE — Original Application (Nordic Pharma, Inc.)
FDA approves Nordic Pharma's TIMOPTIC IN OCUDOSE (timolol maleate) under an original ANDA application.
-
FDA approval · 2021-10-28FDA Approved: PHOSPHOLINE IODIDE — Supplemental Application (Fera Pharmaceuticals, LLC)
FDA approved a supplemental application for phospholine iodide (echothiophate iodide for ophthalmic solution) from Fera Pharmaceuticals, LLC…